Børresen-Dale AL - Search Results

1

Genes harbouring susceptibility SNPs are differentially expressed in the breast cancer subtypes.

Nordgard SH, Johansen FE, Alnaes GI, Naume B, Børresen-Dale AL, Kristensen VN. Nordgard SH, et al. Breast Cancer Res. 2007;9(6):113. doi: 10.1186/bcr1784. Breast Cancer Res. 2007. PMID: 18036273 Free PMC article.

2

Interaction between bcl-2 and p21 (WAF1/CIP1) in breast carcinomas with wild-type p53.

Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen-Dale AL. Bukholm IK, et al. Int J Cancer. 1997 Sep 26;73(1):38-41. doi: 10.1002/(sici)1097-0215(19970926)73:1<38::aid-ijc7>3.0.co;2-2. Int J Cancer. 1997. PMID: 9334807

3

Improved electrophoretic separation of polymorphic short tandem repeats in agarose gels using bis-benzimide.

Kristensen VN, Børresen-Dale AL. Kristensen VN, et al. Biotechniques. 1997 Oct;23(4):634-6. doi: 10.2144/97234bm18. Biotechniques. 1997. PMID: 9343680 Free article. No abstract available.

4

A rare CYP19 (aromatase) variant may increase the risk of breast cancer.

Kristensen VN, Andersen TI, Lindblom A, Erikstein B, Magnus P, Børresen-Dale AL. Kristensen VN, et al. Pharmacogenetics. 1998 Feb;8(1):43-8. doi: 10.1097/00008571-199802000-00006. Pharmacogenetics. 1998. PMID: 9511180

5

High-throughput screening for known mutations by automated analysis of single sequencing reactions.

Kristensen T, Kristensen VN, Børresen-Dale AL. Kristensen T, et al. Biotechniques. 1998 May;24(5):832-5. doi: 10.2144/98245dt04. Biotechniques. 1998. PMID: 9591134 Free article.

6

CYP17 and breast cancer risk: the polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1.

Nedelcheva Kristensen V, Haraldsen EK, Anderson KB, Lønning PE, Erikstein B, Kåresen R, Gabrielsen OS, Børresen-Dale AL. Nedelcheva Kristensen V, et al. Cancer Res. 1999 Jun 15;59(12):2825-8. Cancer Res. 1999. PMID: 10383140

7

Genetic variants of CYP19 (aromatase) and breast cancer risk.

Kristensen VN, Harada N, Yoshimura N, Haraldsen E, Lonning PE, Erikstein B, Kåresen R, Kristensen T, Børresen-Dale AL. Kristensen VN, et al. Oncogene. 2000 Mar 2;19(10):1329-33. doi: 10.1038/sj.onc.1203425. Oncogene. 2000. PMID: 10713674

8

Molecular epidemiology of breast cancer: genetic variation in steroid hormone metabolism.

Kristensen VN, Borresen-Dale AL. Kristensen VN, et al. Mutat Res. 2000 Apr;462(2-3):323-33. doi: 10.1016/s1383-5742(00)00018-1. Mutat Res. 2000. PMID: 10767642 Review.

9

Screening breast cancer patients for Norwegian ATM mutations.

Laake K, Vu P, Andersen TI, Erikstein B, Kåresen R, Lonning PE, Skovlund E, Børresen-Dale AL. Laake K, et al. Br J Cancer. 2000 Dec;83(12):1650-3. doi: 10.1054/bjoc.2000.1519. Br J Cancer. 2000. PMID: 11104561 Free PMC article.

10

High-throughput methods for detection of genetic variation.

Kristensen VN, Kelefiotis D, Kristensen T, Børresen-Dale AL. Kristensen VN, et al. Biotechniques. 2001 Feb;30(2):318-22, 324, 326 passim. doi: 10.2144/01302tt01. Biotechniques. 2001. PMID: 11233601 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

511 results

Search Page

Filters